UNCX
gene geneOn this page
Also known as Uncx4.1
Summary
UNCX (UNC homeobox, HGNC:33194) is a protein-coding gene on chromosome 7p22.3, encoding Homeobox protein unc-4 homolog (A6NJT0). Transcription factor involved in somitogenesis and neurogenesis.
This gene encodes a homeobox transcription factor that is involved in somitogenesis and neurogenesis and is required for the maintenance and differentiation of specific elements of the axial skeleton. This gene also plays a role in controlling the development of connections of hypothalamic neurons to pituitary elements, allowing central neurons to reach the peripheral blood circulation and deliver hormones that control peripheral functions. The expression of this gene is associated with an increased frequency of acute myeloid leukemia.
Source: NCBI Gene 340260 — RefSeq curated summary.
At a glance
- GWAS associations: 42
- Clinical variants (ClinVar): 106 total
- MANE Select transcript:
NM_001080461
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:33194 |
| Approved symbol | UNCX |
| Name | UNC homeobox |
| Location | 7p22.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | Uncx4.1 |
| Ensembl gene | ENSG00000164853 |
| Ensembl biotype | protein_coding |
| Entrez | 340260 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000316333
RefSeq mRNA: 1 — MANE Select: NM_001080461
NM_001080461
CCDS: CCDS34583
Canonical transcript exons
ENST00000316333 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001156936 | 1232872 | 1233291 |
| ENSE00001216591 | 1233520 | 1233695 |
| ENSE00001492647 | 1235832 | 1237326 |
Expression profiles
Bgee: expression breadth broad, 24 present calls, max score 82.93.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.6045 / max 106.5408, expressed in 108 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 76922 | 0.2894 | 80 |
| 76921 | 0.2467 | 74 |
| 76920 | 0.0684 | 30 |
Top tissues by expression
128 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| cerebellum | UBERON:0002037 | 82.93 | gold quality |
| cerebellar cortex | UBERON:0002129 | 82.85 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 82.75 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 81.67 | gold quality |
| hypothalamus | UBERON:0001898 | 55.48 | gold quality |
| substantia nigra | UBERON:0002038 | 53.90 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 51.03 | gold quality |
| metanephros cortex | UBERON:0010533 | 50.91 | gold quality |
| kidney | UBERON:0002113 | 49.40 | gold quality |
| pituitary gland | UBERON:0000007 | 45.42 | gold quality |
| adenohypophysis | UBERON:0002196 | 43.64 | gold quality |
| ganglionic eminence | UBERON:0004023 | 42.55 | gold quality |
| bone marrow cell | CL:0002092 | 42.44 | gold quality |
| colonic epithelium | UBERON:0000397 | 41.07 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 40.71 | gold quality |
| ventricular zone | UBERON:0003053 | 39.99 | gold quality |
| cortex of kidney | UBERON:0001225 | 39.03 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 37.07 | silver quality |
| brain | UBERON:0000955 | 36.87 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| sural nerve | UBERON:0015488 | 35.83 | gold quality |
| bone marrow | UBERON:0002371 | 34.95 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| muscle tissue | UBERON:0002385 | 32.28 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| liver | UBERON:0002107 | 31.70 | gold quality |
| monocyte | CL:0000576 | 31.16 | gold quality |
| leukocyte | CL:0000738 | 30.84 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.20 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.66 |
Regulation
Is transcription factor: yes
Downstream targets (CollecTRI)
4 targets.
| Target | Regulation |
|---|---|
| EGLN1 | |
| EGLN3 | |
| NEUROG2 | Activation |
| UNCX |
JASPAR motifs
| Motif | Name | Family |
|---|---|---|
| MA0721.1 | UNCX | Paired-related HD factors |
| MA0721.2 | UNCX | Paired-related HD factors |
JASPAR matrix evidence (PMIDs): PMID:18585360
Upstream regulators (CollecTRI, top): ARNT, MESP2, UNCX
Literature-anchored findings (GeneRIF, showing 1)
- our findings suggest a novel leukemogenic role of UNCX, associated with epigenetic modifications and with impaired cell proliferation and differentiation in AML. (PMID:28411256)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | uncx4.1 | ENSDARG00000037760 |
| danio_rerio | uncx | ENSDARG00000102976 |
| mus_musculus | Uncx | ENSMUSG00000029546 |
| rattus_norvegicus | Uncx | ENSRNOG00000001284 |
Paralogs (50): ARX (ENSG00000004848), PAX6 (ENSG00000007372), PAX7 (ENSG00000009709), ALX4 (ENSG00000052850), GSC2 (ENSG00000063515), PITX1 (ENSG00000069011), PAX2 (ENSG00000075891), RHOXF1 (ENSG00000101883), CRX (ENSG00000105392), EVX1 (ENSG00000106038), PAX4 (ENSG00000106331), NOBOX (ENSG00000106410), PITX3 (ENSG00000107859), PHOX2B (ENSG00000109132), OTX1 (ENSG00000115507), PRRX1 (ENSG00000116132), VSX2 (ENSG00000119614), ESX1 (ENSG00000123576), PAX8 (ENSG00000125618), PAX1 (ENSG00000125813), RHOXF2 (ENSG00000131721), GSC (ENSG00000133937), RAX (ENSG00000134438), PAX3 (ENSG00000135903), ALX3 (ENSG00000156150), HESX1 (ENSG00000163666), PITX2 (ENSG00000164093), PHOX2A (ENSG00000165462), OTX2 (ENSG00000165588), DRGX (ENSG00000165606), PRRX2 (ENSG00000167157), SHOX2 (ENSG00000168779), OTP (ENSG00000171540), RAX2 (ENSG00000173976), EVX2 (ENSG00000174279), PROP1 (ENSG00000175325), ISX (ENSG00000175329), ALX1 (ENSG00000180318), MIXL1 (ENSG00000185155), SHOX (ENSG00000185960)
Protein
Protein identifiers
Homeobox protein unc-4 homolog — A6NJT0 (reviewed: A6NJT0)
Alternative names: Homeobox protein Uncx4.1
All UniProt accessions (1): A6NJT0
UniProt curated annotations — full annotation on UniProt →
Function. Transcription factor involved in somitogenesis and neurogenesis. Required for the maintenance and differentiation of particular elements of the axial skeleton. May act upstream of PAX9. Plays a role in controlling the development of connections of hypothalamic neurons to pituitary elements, allowing central neurons to reach the peripheral blood circulation and to deliver hormones for control of peripheral functions.
Subcellular location. Nucleus.
Similarity. Belongs to the paired homeobox family. Unc-4 subfamily.
RefSeq proteins (1): NP_001073930* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001356 | HD | Domain |
| IPR009057 | Homeodomain-like_sf | Homologous_superfamily |
| IPR017970 | Homeobox_CS | Conserved_site |
Pfam: PF00046
UniProt features (16 total): compositionally biased region 10, region of interest 4, chain 1, DNA-binding region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A6NJT0-F1 | 59.38 | 0.15 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 58 (showing top):
GOBP_SPINAL_CORD_DEVELOPMENT, GOBP_OLFACTORY_BULB_INTERNEURON_DIFFERENTIATION, GOBP_CARTILAGE_DEVELOPMENT, GOBP_SKELETAL_SYSTEM_DEVELOPMENT, GOBP_NEUROGENESIS, GOBP_FOREBRAIN_DEVELOPMENT, chr7p22, GOBP_FOREBRAIN_GENERATION_OF_NEURONS, MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN, GOBP_ANIMAL_ORGAN_MORPHOGENESIS, GOBP_CELL_AGGREGATION, MARTIN_VIRAL_GPCR_SIGNALING_DN, GOBP_CENTRAL_NERVOUS_SYSTEM_NEURON_DIFFERENTIATION, GOBP_HEAD_DEVELOPMENT, GOBP_OLFACTORY_LOBE_DEVELOPMENT
GO Biological Process (11): cartilage condensation (GO:0001502), pattern specification process (GO:0007389), regulation of gene expression (GO:0010468), dorsal spinal cord development (GO:0021516), olfactory bulb interneuron differentiation (GO:0021889), common myeloid progenitor cell proliferation (GO:0035726), regulation of cell differentiation (GO:0045595), regulation of DNA-templated transcription (GO:0006355), regulation of transcription by RNA polymerase II (GO:0006357), nervous system development (GO:0007399), cell differentiation (GO:0030154)
GO Molecular Function (3): DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), sequence-specific double-stranded DNA binding (GO:1990837), DNA binding (GO:0003677)
GO Cellular Component (2): chromatin (GO:0000785), nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| skeletal system morphogenesis | 1 |
| cartilage development | 1 |
| cell aggregation | 1 |
| multicellular organism development | 1 |
| multicellular organismal process | 1 |
| gene expression | 1 |
| regulation of macromolecule biosynthetic process | 1 |
| spinal cord development | 1 |
| anatomical structure development | 1 |
| olfactory bulb development | 1 |
| forebrain neuron differentiation | 1 |
| cell population proliferation | 1 |
| cell differentiation | 1 |
| regulation of developmental process | 1 |
| regulation of cellular process | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| system development | 1 |
| cellular developmental process | 1 |
| chromatin | 1 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| double-stranded DNA binding | 1 |
| sequence-specific DNA binding | 1 |
| nucleic acid binding | 1 |
| chromosome | 1 |
| cellular anatomical structure | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
1218 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| UNCX | MESP2 | Q0VG99 | 678 |
| UNCX | PAX1 | P15863 | 606 |
| UNCX | UMOD | P07911 | 581 |
| UNCX | SYPL2 | Q5VXT5 | 575 |
| UNCX | MARCHF11 | A6NNE9 | 544 |
| UNCX | TBX6 | O95947 | 533 |
| UNCX | RIPPLY2 | Q5TAB7 | 532 |
| UNCX | MSGN1 | A6NI15 | 521 |
| UNCX | TBX18 | O95935 | 520 |
| UNCX | RIPPLY1 | Q0D2K3 | 509 |
| UNCX | LFNG | Q8NES3 | 501 |
| UNCX | IGFBP5 | P24593 | 473 |
| UNCX | DLL1 | O00548 | 456 |
| UNCX | AJAP1 | Q9UKB5 | 454 |
| UNCX | APOL1 | O14791 | 434 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| KLHL22 | TRAV18 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (4): UNCX (Affinity Capture-RNA), UNCX (Proximity Label-MS), LMNA (Cross-Linking-MS (XL-MS)), UNCX (Affinity Capture-MS)
ESM2 similar proteins: A1YER7, A1YF08, A1YFD8, A1YFY3, A1YG85, A2D4P8, A2D5I1, A2T6X6, A2T756, A2T7H5, A6NCS4, A6NJT0, O08934, O14813, O42230, O43763, O70218, O93367, P06798, P09016, P10284, P10628, P13378, P17277, P17483, P18111, P23683, P23813, P31277, P31310, P35452, P47902, P49640, P50223, P52945, P52946, P52947, P70118, P82976, P97830
Diamond homologs: A1A546, A1YEV8, A1YG25, A2T711, A6NJT0, A6NNA5, A6YP92, G5EC89, G5EDS1, L8E946, O08934, O09113, O14813, O15266, O18381, O35085, O35137, O35602, O35690, O35750, O42115, O42201, O42250, O42356, O42357, O42358, O42477, O42567, O60902, O70137, O73917, O95076, O97039, P0DMV5, P23759, P23760, P24610, P26367, P26630, P29506
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
106 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 100 |
| Likely benign | 5 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
319 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 7:1233287:GTCAG:G | donor_gain | 1.0000 |
| 7:1233288:TCAGG:T | donor_loss | 1.0000 |
| 7:1233292:G:GG | donor_gain | 1.0000 |
| 7:1233691:TTCAG:T | donor_loss | 1.0000 |
| 7:1233692:TCAG:T | donor_loss | 1.0000 |
| 7:1233693:CAGG:C | donor_loss | 1.0000 |
| 7:1233694:AGGTA:A | donor_loss | 1.0000 |
| 7:1233695:GGT:G | donor_loss | 1.0000 |
| 7:1233696:GTAAA:G | donor_loss | 1.0000 |
| 7:1233697:T:A | donor_loss | 1.0000 |
| 7:1235817:ATCC:A | acceptor_gain | 1.0000 |
| 7:1233507:T:TA | acceptor_gain | 0.9900 |
| 7:1233511:T:A | acceptor_gain | 0.9900 |
| 7:1233515:CGCAG:C | acceptor_loss | 0.9900 |
| 7:1233516:GCA:G | acceptor_loss | 0.9900 |
| 7:1233517:CAGAC:C | acceptor_loss | 0.9900 |
| 7:1233518:A:AC | acceptor_loss | 0.9900 |
| 7:1233518:A:AG | acceptor_gain | 0.9900 |
| 7:1233519:G:GC | acceptor_gain | 0.9900 |
| 7:1233519:GA:G | acceptor_gain | 0.9900 |
| 7:1233519:GACTC:G | acceptor_gain | 0.9900 |
| 7:1235817:ATCCG:A | acceptor_gain | 0.9900 |
| 7:1235820:C:CA | acceptor_gain | 0.9900 |
| 7:1235821:G:A | acceptor_gain | 0.9900 |
| 7:1233519:GACT:G | acceptor_gain | 0.9800 |
| 7:1235817:A:AG | acceptor_gain | 0.9800 |
| 7:1235818:T:G | acceptor_gain | 0.9800 |
| 7:1235826:CTCTA:C | acceptor_loss | 0.9800 |
| 7:1235827:TCTA:T | acceptor_loss | 0.9800 |
| 7:1235828:CTAGG:C | acceptor_loss | 0.9800 |
AlphaMissense
3383 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 7:1233564:C:A | R107S | 1.000 |
| 7:1233570:C:A | R109S | 1.000 |
| 7:1233570:C:G | R109G | 1.000 |
| 7:1233570:C:T | R109C | 1.000 |
| 7:1233574:C:T | T110I | 1.000 |
| 7:1233576:A:G | N111D | 1.000 |
| 7:1233578:C:A | N111K | 1.000 |
| 7:1233578:C:G | N111K | 1.000 |
| 7:1233579:T:A | F112I | 1.000 |
| 7:1233579:T:C | F112L | 1.000 |
| 7:1233579:T:G | F112V | 1.000 |
| 7:1233580:T:C | F112S | 1.000 |
| 7:1233580:T:G | F112C | 1.000 |
| 7:1233581:C:A | F112L | 1.000 |
| 7:1233581:C:G | F112L | 1.000 |
| 7:1233583:C:T | T113I | 1.000 |
| 7:1233588:T:A | W115R | 1.000 |
| 7:1233588:T:C | W115R | 1.000 |
| 7:1233590:G:C | W115C | 1.000 |
| 7:1233590:G:T | W115C | 1.000 |
| 7:1233592:A:G | Q116R | 1.000 |
| 7:1233593:G:C | Q116H | 1.000 |
| 7:1233593:G:T | Q116H | 1.000 |
| 7:1233595:T:A | L117Q | 1.000 |
| 7:1233595:T:C | L117P | 1.000 |
| 7:1233604:T:A | L120Q | 1.000 |
| 7:1233604:T:C | L120P | 1.000 |
| 7:1233604:T:G | L120R | 1.000 |
| 7:1233607:A:T | E121V | 1.000 |
| 7:1233608:G:C | E121D | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1000326471 (7:1237825 C>T), RS1000447305 (7:1233228 C>A,G), RS1000675869 (7:1237422 GC>G,GCC), RS1000818604 (7:1232129 C>CA,CG), RS1001026615 (7:1236970 T>A,C,G), RS1001496337 (7:1232388 C>A,T), RS1001516254 (7:1231249 G>C), RS1002301888 (7:1236076 G>C), RS1002580178 (7:1234683 C>T), RS1002608982 (7:1232293 G>A,C), RS1002924570 (7:1232538 C>G,T), RS1004016112 (7:1234498 C>A), RS1004263056 (7:1236461 C>T), RS1004358871 (7:1230989 A>C), RS1004503131 (7:1237434 C>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
42 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001343_10 | Fat distribution (HIV) | 4.000000e-07 |
| GCST001606_3 | Renal function-related traits (sCR) | 5.000000e-11 |
| GCST001607_1 | Renal function-related traits (eGRFcrea) | 1.000000e-10 |
| GCST001610_7 | Renal function-related traits (BUN) | 4.000000e-09 |
| GCST002829_5 | Urate levels in overweight individuals | 1.000000e-06 |
| GCST002934_21 | Zinc levels | 8.000000e-06 |
| GCST003372_32 | Glomerular filtration rate (creatinine) | 9.000000e-14 |
| GCST003372_62 | Glomerular filtration rate (creatinine) | 2.000000e-14 |
| GCST003790_12 | Glomerular filtration rate | 5.000000e-15 |
| GCST003790_40 | Glomerular filtration rate | 1.000000e-08 |
| GCST003790_41 | Glomerular filtration rate | 4.000000e-06 |
| GCST004215_4 | Urea levels | 2.000000e-08 |
| GCST004292_45 | Glomerular filtration rate (creatinine) | 3.000000e-08 |
| GCST005164_3 | GLP-1 levels in response to oral glucose tolerance test (fasting) | 5.000000e-06 |
| GCST005983_32 | Serum uric acid levels | 3.000000e-08 |
| GCST005984_32 | Glomerular filtration rate | 9.000000e-39 |
| GCST005985_50 | Creatinine levels | 1.000000e-37 |
| GCST005986_37 | Blood urea nitrogen levels | 2.000000e-31 |
| GCST005994_2 | Hematocrit | 1.000000e-14 |
| GCST005995_14 | Hemoglobin | 2.000000e-14 |
| GCST005996_26 | Red blood cell count | 3.000000e-12 |
| GCST007344_93 | Estimated glomerular filtration rate | 2.000000e-39 |
| GCST007725_34 | Serum uric acid levels | 5.000000e-10 |
| GCST007876_53 | Estimated glomerular filtration rate | 5.000000e-43 |
| GCST008058_197 | Estimated glomerular filtration rate | 5.000000e-91 |
| GCST008059_112 | Estimated glomerular filtration rate | 7.000000e-62 |
| GCST008060_32 | Estimated glomerular filtration rate | 2.000000e-24 |
| GCST008062_4 | Blood urea nitrogen levels | 7.000000e-57 |
| GCST008064_37 | Chronic kidney disease | 9.000000e-13 |
| GCST008522_93 | Bitter alcoholic beverage consumption | 8.000000e-06 |
EFO canonical traits (10, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004341 | body fat distribution |
| EFO:0004531 | urate measurement |
| EFO:0004307 | glucose tolerance test |
| EFO:0008465 | glucagon-like peptide-1 measurement |
| EFO:0004761 | uric acid measurement |
| EFO:0004348 | hematocrit |
| EFO:0004509 | hemoglobin measurement |
| EFO:0004305 | erythrocyte count |
| EFO:0010092 | bitter alcoholic beverage consumption measurement |
| EFO:0009749 | age at first sexual intercourse measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
24 total (human), top 24 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Tretinoin | affects cotreatment, decreases reaction, increases expression, decreases expression | 2 |
| Valproic Acid | decreases expression, increases methylation | 2 |
| glycolic acid | decreases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, increases expression, decreases reaction | 1 |
| Chir 99021 | affects cotreatment, increases expression, decreases reaction | 1 |
| ramelteon | decreases expression | 1 |
| nilotinib | decreases expression | 1 |
| MT19c compound | decreases expression | 1 |
| Dabigatran | decreases expression | 1 |
| Abacavir | decreases expression | 1 |
| Arsenic | affects methylation | 1 |
| Vehicle Emissions | decreases methylation | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Cadmium | increases abundance, decreases expression | 1 |
| Caffeine | decreases expression | 1 |
| Endosulfan | increases expression | 1 |
| Penicillins | affects cotreatment, increases expression | 1 |
| Phenytoin | decreases expression | 1 |
| Streptomycin | affects cotreatment, increases expression | 1 |
| Thalidomide | decreases expression | 1 |
| Triclosan | decreases expression | 1 |
| Isotretinoin | decreases expression | 1 |
| Cadmium Chloride | decreases expression, increases abundance | 1 |
| Ethylene Glycol | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): adolescent idiopathic scoliosis, restless legs syndrome